Measuring inflammation in asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study looks at a specific kind of inflammation (called Type 2) in people with asthma. Researchers want to see how common it is and how it affects asthma symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with asthma and have started treatment
- You do not have other lung diseases like COPD or lung cancer
- Your asthma is not severe enough to need high-dose inhalers plus other control medicines
- You are not currently in another asthma treatment study
- You have not seen a lung or allergy specialist in the past year for a type of breath test called FeNO
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a simple breath test called FeNO can help doctors diagnose asthma more accurately. It's for people who have symptoms that might be asthma, but haven't been diagnosed yet.
This trial uses a simple inflammation test (inflammometry) to help diagnose asthma more accurately in people aged 6 and older who have been sent by their primary care doctor for standard breathing tests. It aims to improve the diagnosis process and reduce delays.
This trial tests a handheld device that measures nitric oxide in your breath to see if it can help monitor asthma. You may qualify if you have uncontrolled asthma and can use the device at home.
This study is testing a new way to diagnose asthma in children and teens using simple breathing tests. If your regular breathing test wasn't clear, this might give a more accurate answer.
This study compares simple breathing tests (oscillometry and FeNO) used by your primary care doctor against a specialist's diagnosis to see if they can accurately tell if you have asthma or COPD. If you have symptoms like wheezing, cough, or shortness of breath but haven't been diagnosed yet, this trial may help improve how these conditions are found.
This trial studies new technologies to help doctors diagnose asthma and better understand airway inflammation. It may help you (or healthy volunteers, if eligible) by allowing your breathing tests and inflammation markers to be measured with newer diagnostic tools.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.